Mega Genomics
Latest round
- Series A
Last raised
- Oct 2016
Total raised
- $25M
Investors
- 4
About Mega Genomics
Founded in 2016 in Beijing, China, Mega Genomics focuses on genomic testing services. The company has not undergone any notable pivots in its business strategy. Zhe Xiao leads the company as CEO.Mega Genomics specializes in genomic testing services, offering comprehensive analyses of over 700,000 genetic loci and sequencing of more than 180,000 key exonic regions in the human genome. These services assess the risk of various diseases, including hereditary cancers, recessive genetic disorders, and complex diseases. The core product offerings encompass whole-genome testing and whole-exome sequencing packages designed for both adults and children, providing insights into drug efficacy, dietary recommendations, and fitness guidance tailored to individual genetic profiles.The revenue model for Mega Genomics is structured around direct-to-consumer sales of its genomic testing services, which includes flagship offerings like the adult and pediatric whole-exome sequencing packages. Clients typically engage in transactions through a straightforward purchasing process on the company’s platform, where they can select from various testing options. Pricing structures may vary based on the service selected, with each testing package providing detailed assessments of genetic risks and personalized health recommendations. The company fosters partnerships with healthcare providers and research institutions, enabling broader access to its services while enhancing revenue potential through collaborative initiatives.Moving forward, Mega Genomics plans to introduce new products, although specific details and release dates are not outlined. The company is targeting expansion into additional markets with a focus on urban regions in China by 2024.
Who invested in Mega Genomics
4 investors across 1 round
See all investors in Mega Genomics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Oct 27, 2016
Amount
$25M
Investors
Questions about Mega Genomics
Who invested in Mega Genomics?
Mega Genomics has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Mega Genomics raised?
Mega Genomics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Mega Genomics last raise money?
Mega Genomics's most recent round on record is a Series A, in Oct 2016.
What does Mega Genomics do?
Founded in 2016 in Beijing, China, Mega Genomics focuses on genomic testing services.
Where is Mega Genomics headquartered?
Mega Genomics is headquartered in Beijing, China.
Which VCs invest in companies like Mega Genomics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Mega Genomics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Mega Genomics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.